Literature DB >> 15118650

Randomized controlled trial of prenatal zinc supplementation and the development of fetal heart rate.

Mario Merialdi1, Laura E Caulfield, Nelly Zavaleta, Alberto Figueroa, Francesca Dominici, Janet A Dipietro.   

Abstract

OBJECTIVES: This study was undertaken to evaluate whether prenatal zinc supplementation affects maturation of fetal cardiac patterns. STUDY
DESIGN: A randomized double-blind controlled trial among 242 low-income Peruvian women was performed. Beginning at 10 to 16 weeks' gestation, women received supplements containing 60 mg iron, 250 microg folic acid with or without 25 mg zinc. Fetal heart rate (mean FHR, variability [HRV], number of accelerations) and movements (number and amplitude of movement bouts, time spent moving) were electronically monitored monthly from 20 weeks' gestation. Developmental trends were evaluated by supplement type among 195 women who completed the trial and had no serious complications of pregnancy.
RESULTS: Zinc supplementation was associated with lower FHR, greater number of accelerations, and greater HRV. Supplementation effects on HRV and accelerations were more pronounced after 28 weeks' gestation. No differences in motor activity were observed.
CONCLUSION: Prenatal supplementation of zinc-deficient mothers may be beneficial to fetal neurobehavioral development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118650     DOI: 10.1016/j.ajog.2003.09.072

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  20 in total

1.  Maternal gestational zinc supplementation does not influence multiple aspects of child development at 54 mo of age in Peru.

Authors:  Laura E Caulfield; Diane L Putnick; Nelly Zavaleta; Fabiola Lazarte; Carla Albornoz; Ping Chen; Janet A Dipietro; Marc H Bornstein
Journal:  Am J Clin Nutr       Date:  2010-05-19       Impact factor: 7.045

2.  Effect of maternal zinc supplementation on the cardiometabolic profile of Peruvian children: results from a randomized clinical trial.

Authors:  M L Mispireta; L E Caulfield; N Zavaleta; M Merialdi; D L Putnick; M H Bornstein; J A DiPietro
Journal:  J Dev Orig Health Dis       Date:  2016-10-17       Impact factor: 2.401

Review 3.  Zinc supplementation for improving pregnancy and infant outcome.

Authors:  Erika Ota; Rintaro Mori; Philippa Middleton; Ruoyan Tobe-Gai; Kassam Mahomed; Celine Miyazaki; Zulfiqar A Bhutta
Journal:  Cochrane Database Syst Rev       Date:  2015-02-02

4.  Maternal zinc supplementation during pregnancy affects autonomic function of Peruvian children assessed at 54 months of age.

Authors:  Laura E Caulfield; Nelly Zavaleta; Ping Chen; Fabiola Lazarte; Carla Albornoz; Diane L Putnick; Marc H Bornstein; Janet A DiPietro
Journal:  J Nutr       Date:  2010-12-22       Impact factor: 4.798

Review 5.  Zinc in child health and disease.

Authors:  Shinjini Bhatnagar; Uma Chandra Mouli Natchu
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 6.  Effect of zinc supplementation on pregnancy and infant outcomes: a systematic review.

Authors:  Benjamin W Chaffee; Janet C King
Journal:  Paediatr Perinat Epidemiol       Date:  2012-07       Impact factor: 3.980

7.  Maternal zinc supplementation and growth in Peruvian infants.

Authors:  Lora L Iannotti; Nelly Zavaleta; Zulema León; Anuraj H Shankar; Laura E Caulfield
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

8.  Red blood cell metallothionein as an indicator of zinc status during pregnancy.

Authors:  Laura E Caulfield; Carmen M Donangelo; Ping Chen; Jorge Junco; Mario Merialdi; Nelly Zavaleta
Journal:  Nutrition       Date:  2008-07-07       Impact factor: 4.008

Review 9.  Association between Micronutrients and Heart Rate Variability: A Review of Human Studies.

Authors:  Adrian L Lopresti
Journal:  Adv Nutr       Date:  2020-05-01       Impact factor: 8.701

10.  Deficient maternal zinc intake-but not folate-is associated with lower fetal heart rate variability.

Authors:  Marisa N Spann; Jennifer Smerling; Hanna Gustafsson; Sophie Foss; Margaret Altemus; Catherine Monk
Journal:  Early Hum Dev       Date:  2015-02-03       Impact factor: 2.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.